-
Alteplase, sold
under the
brand name
Activase among others, is a
biosynthetic form of
human tissue-type
plasminogen activator (t-PA). It is a thrombolytic...
-
producing types of
recombinant tissue plasminogen activator (rtPA) such as
alteplase, reteplase, and tenecteplase.
These drugs are used in
clinical medicine...
-
Management of
Acute Ischemic Stroke supports considering tenecteplase over
alteplase in
patients without contraindication to
intravenous thrombolytics. Distribution:...
- medications, such as
anticoagulants and
thrombolytic tpA
medication (such as
alteplase)
which can
increase the
bleeding risk.
Effective treatment is complex...
- (
alteplase), but the
modifications give
reteplase a
longer half-life of 13–16 minutes.
Reteplase also
binds fibrin with
lower affinity than
alteplase,...
-
manufactured using recombinant techniques and is sold as
alteplase, reteplase, and tenecteplase.
Alteplase was the
first of
these versions to go on the market...
- (Kabikinase)
Urokinase Recombinant tissue plasminogen activators (rtPA)
Alteplase (Activase or Actilyse)
Reteplase (Retavase)
Tenecteplase Anistreplase...
- production. The
thrombolytic medication against myocardial infarction alteplase (Activase) was
approved by the US Food and Drug
Administration in 1987...
- high and therefore,
treatment using streptokinase is not recommended.
Alteplase is a
recombinant tissue plasminogen activator which enhances the conversion...
- -arit for
antiarthritic agents (e.g. lobenzarit) -ase for
enzymes (e.g.
alteplase) -azepam or -azolam for
benzodiazepines (e.g.
diazepam and alprazolam)...
